1. Home
  2. ALDX vs CCIX Comparison

ALDX vs CCIX Comparison

Compare ALDX & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • CCIX
  • Stock Information
  • Founded
  • ALDX 2004
  • CCIX 2023
  • Country
  • ALDX United States
  • CCIX United States
  • Employees
  • ALDX N/A
  • CCIX N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • CCIX
  • Sector
  • ALDX Health Care
  • CCIX
  • Exchange
  • ALDX Nasdaq
  • CCIX Nasdaq
  • Market Cap
  • ALDX 398.3M
  • CCIX 394.1M
  • IPO Year
  • ALDX 2014
  • CCIX 2024
  • Fundamental
  • Price
  • ALDX $2.12
  • CCIX $10.71
  • Analyst Decision
  • ALDX Strong Buy
  • CCIX
  • Analyst Count
  • ALDX 3
  • CCIX 0
  • Target Price
  • ALDX $9.67
  • CCIX N/A
  • AVG Volume (30 Days)
  • ALDX 3.3M
  • CCIX 26.4K
  • Earning Date
  • ALDX 05-01-2025
  • CCIX 01-01-0001
  • Dividend Yield
  • ALDX N/A
  • CCIX N/A
  • EPS Growth
  • ALDX N/A
  • CCIX N/A
  • EPS
  • ALDX N/A
  • CCIX 0.33
  • Revenue
  • ALDX N/A
  • CCIX N/A
  • Revenue This Year
  • ALDX N/A
  • CCIX N/A
  • Revenue Next Year
  • ALDX N/A
  • CCIX N/A
  • P/E Ratio
  • ALDX N/A
  • CCIX $31.98
  • Revenue Growth
  • ALDX N/A
  • CCIX N/A
  • 52 Week Low
  • ALDX $1.14
  • CCIX $10.00
  • 52 Week High
  • ALDX $7.20
  • CCIX $11.17
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 26.33
  • CCIX N/A
  • Support Level
  • ALDX $1.79
  • CCIX N/A
  • Resistance Level
  • ALDX $2.32
  • CCIX N/A
  • Average True Range (ATR)
  • ALDX 0.49
  • CCIX 0.00
  • MACD
  • ALDX -0.32
  • CCIX 0.00
  • Stochastic Oscillator
  • ALDX 17.53
  • CCIX 0.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About CCIX Churchill Capital Corp IX Ordinary Shares

Churchill Capital Corp IX is a blank check company.

Share on Social Networks: